A new magic mushroom drug could treat depression without psychedelic hallucinations

Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending side effects. Researchers created modified versions of psilocin - the active form of psilocybin from magic mushrooms - that still target key serotonin pathways linked to depression and other brain disorders but appear to cause far fewer psychedelic-like effects.